Day 1
9:00 AM – 10:30 AM: Session 1: Introduction to Menopause Chair Axelle Pintiaux (Uliège & Linda Amerijckx UZA)
9: 00 –9:30 Epidemiology of menopause and related complications (Serge Rozenberg ULB)
menopause Epidemiology 21.03.25 W
9:30-10:00 Definition and stages (Straw, reproduction, late reproduction, Perimenopause, Menopause, Postmenopause), related changes (Linda Ameryckx UZA)
10:00-10:30 Physiology: Hormonal changes during menopause, the importance of KNDy, NKB signaling, Neurokinin and antagonists) (Axelle Pintiaux ULiège)
Learning Activities: Interactive presentation and discussion on basic physiology.
10:45 AM – 12:15 PM: Session 2: Common Symptoms and consequences of Menopause and how to measure them Chair: Anne Firquet (ULiège) Serge Rozenberg (ULB)
- 10:45-11:15 Hot flashes, night sweats, and sleep disturbances: differential diagnosis and measurements (Anne Firquet ULiège)
- 11:15-11:45 Vaginal dryness and urinary symptoms (Genitourinary syndrome) : differential diagnosis and measurements (Aurélie Joris ULB)
- 11:45-12:15 Lifestyle changes, herbal remedies & Non-Hormonal treatments: SSRIs, GABA (Axelle Pintiaux Uliège)
1:15 PM – 2:45 PM: Session 3: Menopause Hormone Therapy (MHT) Chair Axelle Pintiaux (ULiège), Serge Rozenberg (ULB)
1: 15-1:45 Pharmacology and Regimens (Anne Firquet ULiège)
1:45-2:15 Indications of MHT, benefits & Managing Complications /Side Effects (Eveline Markowicz Brussels)
Menopause care EM 20250319 13h30
2:15- 2:45 Breast health during menopause Patrick Neven (KUL)
Sessions 4-5: Hormonal and Non-Hormonal Treatment Options & Special Populations
Chair: Axelle Pintiaux (ULiège) & Serge Rozenberg (ULB)
3.00 PM – 3.30 PMOsteoporosis risk
Olivier Bruyère (ULiège)
Osteoporosis risk – menopause care – Mars 2025 (1)
3:30-4:00 Osteoporosis treatment (Charlotte Verroken UGent)
20250321 Treatment of osteoporosis – Belgian Menopause Society
4:00-4:30 Revisiting Hormonal Treatments and Thrombosis Risks: New Insights and Perspectives (Cidric Hermans UCL)
Lecture HRT March 2025 CH Final version bis
4:30-5:00 Urinary incontinence and pelvic floor health (Silke Vasseur VUB)
Urinary incontinence and pelvic health BMS 2025 1
5 PM – 5:30 PM: Q&A and Day 1 Wrap-Up Serge Rozenberg (ULB)
Day 2: Practical Skills and Advanced Management
Session 6: Evaluate risk factors and special populations
9-9:30 Fertility issues in Premature Ovarian Insufficiency (Asma Sassi ULB)
9:30-10: 00 Early or premature menopause: Causes and management (Axelle Pintaiux ULG)
10-10:30 Cardiovascular risk, menopause and MHT (Bharati Shivalkar)
CVD risk and menopause.22.03.2025.Final
Session 7 Special populations
10: 45- 11: 15 Mood changes, depression and memory concerns (Herman Depypere (UGent)
11; 15- 11: 45 Breast cancer risk assessment Herman Depypere (UGent)
11:45-12:15 Potential risks, Contra-indications & Monitoring and Assessment of MHT Efficacy and Safety (Linda Ameryckx UZA)
1:15 – 1:45 : Session 5: Special Populations and Cultural Sensitivity
1:15-1:45 A New paradigm: NK3 and NK1,3 antagonsits Serge Rozenberg (ULB)
1:45-2:15 Evaluation and Prevention and treatment of Neurognognitive disorders Joachim Schulz (ULB)
2:15-2:45 How to manage a menopause consultation : (Eveline Markowicz, Delta Brussels)
Menopause Consultation EM 20250319 13h30 (1)
3-3:30 Hands-on practice of pelvic floor exercises and demonstration of treatment options (vaginal creams, pessaries). Elise MAes (VUB)
3:30-4:00 Natural vs. Induced Menopause (Surgical or Chemotherapy-related) Daphné ‘T Kint de Roodenbeeke (ULB)
Menopause – Workshop 03-2025 (2)
4:00-4:30 Vulvovaginal atrophy & Genito Urinary Syndrome: Treatments Serge Rozenberg (ULB) –
menopause VVA THERAPY 21.03.25 –f (1)
16-30-17:30 cases presentations & Wrap up Serge Rozenberg Axelle Pintiaux Anne Firquet Herman Depypere